Telemedicine in acute stroke care: The TESSA model

Journal of Telemedicine and Telecare

Volumn 17, Issue 5, 2011, Pages 268-272

  Johansson, Tim ^a   Mutzenbach, Sebastian Johannes ^b   Ladurner, Gunther ^b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b Christian Doppler Klinik   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE DISEASE; ADULT; AGED; ARTICLE; AUSTRIA; FEMALE; FIBRINOLYTIC THERAPY; FOLLOW UP; HEALTH CARE PLANNING; HUMAN; MALE; MEDICINE; METHODOLOGY; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; STROKE; TELEMEDICINE; TIME; TREATMENT OUTCOME; VIDEOCONFERENCING;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MEDICALLY UNDERSERVED AREA; MEDICINE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE; TELEMEDICINE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME; VIDEOCONFERENCING;

EID: 80051574756     PISSN: 1357633X     EISSN: 17581109     Source Type: Journal    
DOI: 10.1258/jtt.2011.101213     Document Type: Article

References (15)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-1757
2. Organised inpatient (stroke unit) care for stroke. Stroke Unit Trialists' Collaboration. Cochrane Database Syst Rev 2000:CD000197
3. Wahlgren N, Ahmed N, Dávalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008;372:1303-1309
4. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329
5. Wardlaw JM, Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev 2003:CD000213
6. Deshpande A, Khoja S, McKibbon A, Rizo C, Jadad AR. Telehealth for acute stroke management (Telestroke): systematic review of analytic studies and environmental scan of relevant initiatives. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH), 2008
7. Fisher M. Developing and implementing future stroke therapies: the potential of telemedicine. Ann Neurol 2005;58:666-671
8. Audebert H. Telestroke: effective networking. Lancet Neurol 2006;5:279-282
9. Johansson T, Wild C. Telemedicine in acute stroke management: systematic review. Int J Technol Assess Health Care 2010;26:149-155
10. Johansson T, Wild C. Telemedicine in stroke management - systematic review. See http://eprints.hta.lbg.ac.at/844/1/HTA-Projektbericht_Nr29. pdf (last checked 27 January 2011)
11. Bundesinstitut für Qualität im Gesundheitswesen. Stroke-Unit-Register. See http:// www.goeg.at/index.php?pid=arbeitsbereichedetail&ab= 179&smark=stroke&noreplace=yes (last checked 26 January 2011)
12. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587
13. Hill MD, Buchan AM. Thrombolysis for acute ischemic stroke: results of the Canadian Alteplase for Stroke Effectiveness Study. CMAJ 2005;172:1307-1312
14. Schwab S, Vatankhah B, Kukla C, et al. Long-term outcome after thrombolysis in telemedical stroke care. Neurology 2007;69:898-903
15. Meyer BC, Raman R, Hemmen T, et al. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomized, blinded, prospective study. Lancet Neurol 2008;7:787-795